Abstract
Introduction: For patients with node positive disease who are exceptional responders for neo-adjuvant treatment (NAT), targeted axillary dissection (TAD) or sentinel node biopsy (SNB) with removal of minimum three nodes may be offered for staging. We compared clinicopathological outcomes of patients treated with TAD/SNB to ANC after NAT for node positive disease in three units in the West of Scotland.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
